Navigation Links
ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
Date:9/27/2007

HALIFAX, Sept. 27 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT) finalizes an important step in its progress with the last appointment to its scientific advisory board (SAB), international oncology expert, Dr. Neil Berinstein.

Dr. Berinstein is the Global Head of the Cancer Vaccine Program at sanofi pasteur, and a professor at the University of Toronto's Department of Medicine. He has a long track record in fundamental research and has a significant publication record in the area of normal and malignant B cell biology, including articles, abstracts and book chapters on immunotherapeutic approaches for cancer including cancer vaccines. He was recently appointed vice-president of the Sabin Institute Cancer vaccine consortium. Dr. Berinstein received an MD from the University of Manitoba, and completed training programs at the University of Toronto in Internal Medicine and Medical Oncology. Following this, he spent four years as a post-doctoral fellow in Dr. Ron Levy's Lab at Stanford University working in the area of immunotherapy for cancer.

"IVT has very promising science," remarked Dr. Berinstein. "Their work is particularly interesting to me, and my commitment to new immunotherapeutic approaches for patients with cancer. "

ImmunoVaccine Technologies Inc. has been actively recruiting members to its SAB in preparation for its Phase I clinical trials, and sees this final appointment as a major stepping stone to that goal.

"This final appointment is one of the last steps before our Phase I clinical trials," said Dr. Martin Kast, chair of the scientific advisory board. "Dr. Berinstein's experience and insight are reflective of the quality of professionals that our exciting projects have attracted," continued Kast.

"Dr. Berinstein is a valuable addition to the team, and represents a pivotal point in our ongoing plan to introduce our patented vaccine platform," commented Dr. Randal Chase, president and CEO of IVT.

ImmunoVa
'/>"/>

SOURCE ImmunoVaccine Technologies Inc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCal..."Company") (TSX:ONC; NASDAQ: ONCY ) announced toda... unit offering, the underwriters have exercised in... additional 637,500 units. Each unit is comprised ...hase warrant, and was sold at a price of US$3.00 p...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*B...ts novel oral JAK2 inhibitor, SB1518, at The Ameri...Exposition in New Orleans. ,, Data will be pres...e-escalation trial of SB1518 detailing its safety,...(PK/PD) profile in dose levels ranging from 100 to...
(Date:12/2/2009)... The Scientist, a leading scie... Photometrics’ Evolve “Intelligent&rdq...o;s “Top 10 Innovations of 2009. , ...volve ™ EMCCD camera from Photometrics &re...e CCD and EMCCD cameras for the life sciences, was...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repo...report is available in its catalogue: ,, Indus...p://www.reportlinker.com/p0164431/Industrial-Enzym... Enzymes market is an oligopoly with few strong pl...he market activities. Keen competition and commodi...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...ation Kit , , Tr... activity than those from other E. , ...synthesis of a wide range , of prokaryoti...nslation and high protein yield , , ...ave it all with the the , Activ...
... Orders of magnitude better DNA , ... Perform DNA digestion and sample ,..., Preserve RNA quality , ... choice for , the removal of co... preparation for RT-PCR. <A , ...
...igh cost , and long turn-around times... siRNA. The new Silencer siRNA Construction K...time and money so now you can expand , ...nts. More genes or , more regions of ...e , cost of chemically synthesized si...
Other Biology Technology:Translate High Yields of Active Protein 2Translate High Yields of Active Protein 3The Fastest, Simplest, and Most Effective Way to Remove DNA Contamination 2The Fastest, Simplest, and Most Effective Way to Remove DNA Contamination 3Test More siRNAs for Less 2Test More siRNAs for Less 3
(Date:12/2/2009)... strengthen the evidence that people who smoke cig...ed risk for developing colorectal cancer, even aft...ovides one more reason not to smoke, or to quit as...Thun, M.D., M.S., vice president emeritus, epidemi...ncer Society. "Colorectal cancer should be added t...
(Date:12/2/2009)...ondhand smoke for a prolonged period of time and i...ncer, even in women who never smoked cigarettes th...o side-stream smoke could increase risk of breast ...olds, Ph.D., senior research scientist at the Nort...While no single epidemiologic study can answer the...
(Date:12/2/2009)... of Georgia College of Veterinary Medicine have ma...new avenues for treating Ichthyophthirius multifil...an parasite that commonly attacks freshwater fish....archers found that Ich harbors two apparently symb...are usually found free-living, and Rickettsia, whi...
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3Advanced Health Media Named to Deloittes 2009 Technology Fast 500 28TM 29 5680 1Advanced Health Media Named to Deloittes 2009 Technology Fast 500 28TM 29 5680 2Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer 5677 1Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer 5677 2Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer 5677 3American Academy of Ophthalmology President leads alliance work to rebuild health care in Iraq 60068 1American Academy of Ophthalmology President leads alliance work to rebuild health care in Iraq 60068 2
... sperm-producing stem cells found in testicles cou...future use. A team in the Netherlands has successf... and cultured them inside mouse testes. The hope i... is a very promising route to help young cancer pa...Utrecht University, Netherlands, told participants...
...ug may be effective against not only multi drug-re... first compound to treat the latent stage of infec...day at the 2006 ASM Biodefense Research Meeting. ...s a very different mechanism of action from any ot... have identified no cross resistance with existing...
...d with an increased risk of the most common type o...lationship between mobile phone use and risk of gl...today. , The four year study by the Universities o...te of Cancer Research, London found those who had ...r overall risk of developing this type of tumour. ...
Other Biology News:Testes to incubate stem cells 2Experimental TB drug effective against resistant and latent mycobacterium tuberculosis 2Mobile phone use not linked to increased risk of glioma brain tumours 2
...ay studies, protein-protein interaction studies, a...uilt on the flexible and powerful Paraflo microflu... are available as part of our comprehensive Custom...t Probe content is completely customer specified....
...lick image analysis software for microarray includ...on for high quality and high throughput array syst...hs robust algorithms, actual spot boundary, flexib...ection and dust removal, enhancing the accuracy of...
a-Hyb Hybridization Station from Miltenyi Biotec
...ocyte Progenitors, Rabbit, and media. Cryo-preserv... at passage 25 (approx), supplied with kit (500 mL...d as a long-term culture, and is guaranteed to pro...rom the date supplied, when used with the recommen...
Biology Products: